Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Net Assets

v3.23.2
Consolidated Statements of Changes in Net Assets - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period (in shares)   78,463,599     78,463,599  
Balance at beginning of period $ 2,172,922 $ 2,108,586 $ 1,873,654 $ 1,788,846 $ 2,108,586 $ 1,788,846
Public offering of common stock, net of offering costs 43,204 40,896 25,633 63,522    
Share‑based compensation 4,087 4,100 3,596 2,818    
Purchase of vested stock for employee payroll tax withholding (5,546) (404) (4,895)      
Dividend reinvestment (in shares)         374,173 246,199
Dividend reinvestment 6,880 7,808 5,000 4,813 $ 14,688 $ 9,813
Amortization of directors’ deferred compensation 109 121 130 147    
Issuance of restricted stock, net of forfeited shares 0   0      
Dividends to stockholders (73,224) (67,777) (52,704) (51,695)    
Net increase resulting from operations $ 106,516 79,592 14,749 65,203 $ 186,107 79,953
Balance at ending of period (in shares) 81,026,676       81,026,676  
Balance at ending of period $ 2,254,948 $ 2,172,922 $ 1,865,163 $ 1,873,654 $ 2,254,948 $ 1,865,163
Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period (in shares) 79,794,089 78,506,816 72,370,407 70,737,021 78,506,816 70,737,021
Balance at beginning of period $ 797 $ 784 $ 723 $ 707 $ 784 $ 707
Public offering of common stock, net of offering costs (in shares) 1,096,514 1,058,914 662,828 1,502,430    
Public offering of common stock, net of offering costs $ 11 $ 11 $ 7 $ 15    
Purchase of vested stock for employee payroll tax withholding (in shares) (140,569) (10,489) (115,071)      
Purchase of vested stock for employee payroll tax withholding $ (1)   $ (1)      
Dividend reinvestment (in shares) 174,891 199,282 132,156 114,043    
Dividend reinvestment $ 2 $ 2 $ 1 $ 1    
Issuance of restricted stock, net of forfeited shares (in shares) 506,081 39,566 467,238 16,913    
Issuance of restricted stock, net of forfeited shares $ 5   $ 5      
Balance at ending of period (in shares) 81,431,006 79,794,089 73,517,558 72,370,407 81,431,006 73,517,558
Balance at ending of period $ 814 $ 797 $ 735 $ 723 $ 814 $ 735
Additional Paid-In Capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period 2,083,175 2,030,531 1,807,739 1,736,346 2,030,531 1,736,346
Public offering of common stock, net of offering costs 43,193 40,885 25,626 63,507    
Share‑based compensation 4,087 4,100 3,596 2,818    
Purchase of vested stock for employee payroll tax withholding (5,545) (404) (4,894)      
Dividend reinvestment 6,878 7,806 4,999 4,812    
Amortization of directors’ deferred compensation 109 121 130 147    
Issuance of restricted stock, net of forfeited shares (5)   (5)      
Dividends to stockholders 149 136 114 109    
Balance at ending of period 2,132,041 2,083,175 1,837,305 1,807,739 2,132,041 1,837,305
Total Undistributed (Overdistributed) Earnings            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at beginning of period 88,950 77,271 65,192 51,793 77,271 51,793
Dividends to stockholders (73,373) (67,913) (52,818) (51,804)    
Net increase resulting from operations 106,516 79,592 14,749 65,203    
Balance at ending of period $ 122,093 $ 88,950 $ 27,123 $ 65,192 $ 122,093 $ 27,123